GENE ONLINE|News &
Opinion
Blog

2025-04-14|

DrugPatentWatch Article: Generic Drug Success Hinges on High-Value Product Selection and Strong Commercial Teams

by Mark Chiang
Share To

NEWSFLASH

Generic drug manufacturers can improve their odds of success in the market by focusing on several key strategies when launching new products, according to a recent article published by DrugPatentWatch. The article identifies the importance of selecting the right product, conducting thorough market research, building a strong commercial team, developing a sound pricing strategy, and executing a well-planned launch. These elements work together to enable manufacturers to have a greater impact in the generic drug market. The DrugPatentWatch article elaborates on these strategies, noting that manufacturers should prioritize high-value, high-volume products that face limited competition. Thorough market research is also crucial to understanding market dynamics, the competitive landscape, and patient needs. Furthermore, assembling a commercial team with expertise in sales, marketing, and distribution ensures effective market penetration. The article emphasizes that balancing profitability with affordability for both patients and payers is essential when creating a pricing strategy. Finally, the article stresses the need for a well-coordinated launch that involves stakeholders, manages supply chain risks, and monitors market trends.

Newsflash | Powered by GeneOnline AI
Date: April 14, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Related Post
The Latest Talk in Cancer Immunotherapy: A Brief Overview of Developments & Current Players in the Exosome Space
2025-04-23
LATEST
The Latest Talk in Cancer Immunotherapy: A Brief Overview of Developments & Current Players in the Exosome Space
2025-04-23
Unlocking the Gut Code: Japan’s Pharmaceutical Sector Explores the Future of Microbiome Therapeutics
2025-04-23
Advancing Pharmaceutical Regulatory Cooperation in Asia: The Vision and Challenges of GMP Inspection Reliance
2025-04-23
The Digital Revolution of Drug Labelling: FHIR and the Global Blueprint for e-Labelling
2025-04-23
Cross-Border Trust and Transparency: The New Landscape of Bridging the Regulatory Review in the Asia-Pacific
2025-04-23
From Cancer to Cosmetics, Physiological to Pathological – The Field of Exosomes Full of Endless Opportunities
2025-04-22
Sumitomo Pharma’s Comeback Story: Reinventing a Century-Old Giant in a Post-Patent Era
2025-04-22
EVENT
2025-04-21
World Vaccine Congress Washington 2025
Washington, U.S.A
2025-04-25
AACR Annual Meeting 2025
Chicago, U.S.A
2025-04-26
SABPA OC/LA 17th Annual Biomedical Forum
Irvine, California, United States
2025-05-03
29th Taiwan Joint Cancer Conference 2025
Taipei, Taiwan
2025-05-05
Swiss Biotech Day 2025
Basel, Switzerland
2025-05-13
ASGCT 28th Annual Meeting 2025
New Orleans, U.S.A.
Scroll to Top